Kulke MH - Search Results

1

Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.

Duerr EM, Mizukami Y, Ng A, Xavier RJ, Kikuchi H, Deshpande V, Warshaw AL, Glickman J, Kulke MH, Chung DC. Duerr EM, et al. Among authors: kulke mh. Endocr Relat Cancer. 2008 Mar;15(1):243-56. doi: 10.1677/ERC-07-0194. Endocr Relat Cancer. 2008. PMID: 18310291

2

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. Cancer. 2004 Sep 1;101(5):934-9. doi: 10.1002/cncr.20466. Cancer. 2004. PMID: 15329900 Free article. Clinical Trial.

3

Advances in the treatment of neuroendocrine tumors.

Kulke M. Kulke M. Curr Treat Options Oncol. 2005 Sep;6(5):397-409. doi: 10.1007/s11864-005-0043-9. Curr Treat Options Oncol. 2005. PMID: 16107243 Review.

4

Carcinoid tumors.

Raut CP, Kulke MH, Glickman JN, Swanson RS, Ashley SW. Raut CP, et al. Among authors: kulke mh. Curr Probl Surg. 2006 Jun;43(6):383-450. doi: 10.1067/j.cpsurg.2006.03.002. Curr Probl Surg. 2006. PMID: 16781906 Review. No abstract available.

5

Gastrointestinal neuroendocrine tumors: a role for targeted therapies?

Kulke MH. Kulke MH. Endocr Relat Cancer. 2007 Jun;14(2):207-19. doi: 10.1677/ERC-06-0061. Endocr Relat Cancer. 2007. PMID: 17639038 Review.

6

High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss.

Kulke MH, Freed E, Chiang DY, Philips J, Zahrieh D, Glickman JN, Shivdasani RA. Kulke MH, et al. Genes Chromosomes Cancer. 2008 Jul;47(7):591-603. doi: 10.1002/gcc.20561. Genes Chromosomes Cancer. 2008. PMID: 18383209

7

Activity of sunitinib in patients with advanced neuroendocrine tumors.

Kulke MH, Lenz HJ, Meropol NJ, Posey J, Ryan DP, Picus J, Bergsland E, Stuart K, Tye L, Huang X, Li JZ, Baum CM, Fuchs CS. Kulke MH, et al. J Clin Oncol. 2008 Jul 10;26(20):3403-10. doi: 10.1200/JCO.2007.15.9020. J Clin Oncol. 2008. PMID: 18612155 Clinical Trial.

8

Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth.

Fujiki K, Duerr EM, Kikuchi H, Ng A, Xavier RJ, Mizukami Y, Imamura T, Kulke MH, Chung DC. Fujiki K, et al. Among authors: kulke mh. Gastroenterology. 2008 Sep;135(3):907-16, 916.e1-2. doi: 10.1053/j.gastro.2008.06.034. Epub 2008 Jul 23. Gastroenterology. 2008. PMID: 18655788 Free PMC article.

9

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O'Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J. Klimstra DS, et al. Among authors: kulke mh. Am J Surg Pathol. 2010 Mar;34(3):300-13. doi: 10.1097/PAS.0b013e3181ce1447. Am J Surg Pathol. 2010. PMID: 20118772

10

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, Jensen RT; North American Neuroendocrine Tumor Society (NANETS). Kulke MH, et al. Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168. Pancreas. 2010. PMID: 20664472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page